Mohan P, Ramu B, Bhaskar E, Venkataraman J

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 15-20
Archivo PDF: 263.63 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-8.

2. Brann OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001: 3(4): 285-92.

3. Corredoira JM, Ariza J, Pallares R, Carratalá J, Viladrich PF, Rufí G, Verdaguer R, et al. Gram-Negative Bacillary Cellulitis in Patients with Hepatic Cirrhosis. Eur J Clin Microbiol Infect Dis 1994; 13: 19-24.

4. Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am J Gastroenterol 1993; 88: 2067-71.

5. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-58.

6. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia- Tsao G, Patch D, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54(5): 718-25.

7. Morris A. Cellulitis and Erysipelas. Clin Evid 2003; (9): 1804-9.

8. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissue. N Engl J Med 1996; 334: 240-45.

9. Yoon TY, Jung SK, Chang SH. Cellulitis due to Escherichia coli in three immunocompromised subjects. Br J Dermatol 1998; 139(5): 885-8.

10. Castanet J, Lacour JP, Perrin C, Bodokh I, Dor JF, Ortonne JP. Escherichia coli cellulitis: two cases. Acta Derm Venereol 1992; 72(4): 310-1.

11. Yael Horowitz, Ami D Sperber, Yaniv Almog. Gram-Negative cellulitis complicating cirrhosis. Mayo Clin Proc 2004; 79: 247-50.

12. Liu BM, Hsiao CT, Chung KJ, Kung CT, Hung SC, Liu PP. Hemorrhagic bullae represent an ominous sign for cirrhotic patients. J Emerg Med 2008; 34(3): 277-81. E-pub 2007 Nov 5.

13. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.

14. Bjornboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1972; 1: 58-60.

15. Triger DR, Wright R. Hyperglobulinaemia in liver disease. Lancet 1973; 1(7818): 1494-6.

16. Simjee AE, Hamilton-Miller JM, Thomas HC, Brumfitt W, Sherlock S. Antibodies to Escherichia coli in chronic liver disease. Gut 1975; 16: 871-5.

17. Staun-Olsen P, Bjorneboe M, Prytz H, Thomsen AC, Orskov F. Escherichia coli antibodies in alcohol liver disease. Correlation to alcohol consumption, alcoholic hepatitis and serum IgA. Scand J Gastroenterol 1983; 18: 889-96.

18. Fierer J, Finley F. Deficient serum bactericidal activity against E. coli in patients with cirrhosis of the liver. J Clin Invest 1979; 63: 912-21.

19. Dupuy A, Benchikhi H, Roujeau J-C, Bernard P, Vaillant L, Chosidow O, Sassolas B, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999; 318(7198): 1591-4.

20. Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver 1991; 11(6): 334-9.

21. Liu BM, Chung KJ, Chen CH, Kung CT, Ko SF, Liu PP, Chang HW. Risk factors for the outcome of cirrhotic patients with soft tissue infections. J Clin Gastroenterol 2008; 42(3): 312-6.

22. de Mattos AA, Coral GP, Menti E, Valiatti F, Kramer C. Bacterial infection in cirrhotic patient. Arq Gastroenterol 2003; 40(1): 11-5. E-pub 2003 Oct.